UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Clinical experience with infliximab biosimilar in psoriasis

British journal of dermatology (1951), 2017-12, Vol.177 (6), p.e347-e348

2017

Volltextzugriff (PDF)

Induced Preference Improves Offspring Fitness in a Phytopathogen Vector

Environmental entomology, 2017-10, Vol.46 (5), p.1090-1097

2017

Volltextzugriff (PDF)

Tuscan consensus on the diagnosis and treatment of hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, 2019-10, Vol.33 (S6), p.21-24

2019

Volltextzugriff (PDF)

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients

British journal of dermatology (1951), 2011-03, Vol.164 (3), p.645-647

2011

Volltextzugriff (PDF)

Lichen planus triggered by CT‐P13 and recurrence during secukinumab treatment

British journal of dermatology (1951), 2018-01, Vol.178 (1), p.303-304

2018

Volltextzugriff (PDF)

Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas

Archives of dermatological research, 2024-05, Vol.316 (6), p.272, Article 272

2024

Volltextzugriff (PDF)

Clinical experience with the etanercept biosimilar SB4 in psoriatic patients

International journal of clinical pharmacy, 2019-02, Vol.41 (1), p.9-12

2019

Volltextzugriff (PDF)

Risk of acute infections in psoriatic patients during biologic therapies is linked to gender

Journal of the European Academy of Dermatology and Venereology, 2019-10, Vol.33 (10), p.e362-e364

2019

Volltextzugriff (PDF)

Clinical characteristics of psoriasis in inflammatory bowel disease patients

Journal of the European Academy of Dermatology and Venereology, 2017-09, Vol.31 (9), p.e414-e416

2017

Volltextzugriff (PDF)

First case of secukinumab successful therapy in a very elderly psoriatic patient

Dermatologic therapy, 2018-09, Vol.31 (5), p.e12668-n/a

2018

Volltextzugriff (PDF)

Itch in psoriasis: epidemiology, clinical aspects and treatment options

Clinical, cosmetic and investigational dermatology, 2009-02, Vol.2 (default), p.9-13

2009

Volltextzugriff (PDF)

Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature

Journal of the European Academy of Dermatology and Venereology, 2017-11, Vol.31 (11), p.e486-e486

2017

Volltextzugriff (PDF)

Reduction in psoriasis related pruritus during biologic therapy

Dermatologic therapy, 2017-05, Vol.30 (3), p.n/a

2017

Volltextzugriff (PDF)

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study

Clinical, cosmetic and investigational dermatology, 2023-01, Vol.16, p.847-852

2023

Volltextzugriff (PDF)

Female mate preference in an invasive phytopathogen vector: how learning may influence mate choice and fecundity in Diaphorina citri

Entomologia experimentalis et applicata, 2017-07, Vol.164 (1), p.16-26

2017

Volltextzugriff (PDF)

Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result

Dermatologic therapy, 2013-01, Vol.26 (1), p.77-78

2013

Volltextzugriff (PDF)

Development of MGUS in psoriatic patients: a possible undiagnosed event during anti-TNF-α-treatment

Journal of the European Academy of Dermatology and Venereology, 2012-11, Vol.26 (11), p.1444-1448

2012

Volltextzugriff (PDF)

Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities

Journal of the European Academy of Dermatology and Venereology, 2010-05, Vol.24 (5), p.555-560

2010

Volltextzugriff (PDF)

Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies

Current medical research and opinion, 2009-09, Vol.25 (9), p.2311-2316

2009

Volltextzugriff (PDF)

Tuberculosis reactivation risk in dermatology

Journal of rheumatology. Supplement, 2014-05, Vol.91, p.65

2014

Volltextzugriff (PDF)

Reduction in psoriasis related pruritus during biologic therapy: Pruritus control in moderate to severe psoriasis

Dermatologic therapy, 2017-05, Vol.30 (3), p.e12442

2017

Volltextzugriff (PDF)

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients: Anti-TNF-α in patients with HBV or HCV and psoriasis

British journal of dermatology (1951), 2011-02, p.no-no

2011

Volltextzugriff (PDF)

Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result: Efficacy of acitretin in nail psoriasis

Dermatologic therapy, 2013-01, Vol.26 (1), p.77-78

2013

Volltextzugriff (PDF)

Cutaneous Non-Tuberculous Mycobacterial Infections: Clinical Clues and Treatment Options

Current treatment options in infectious disease, 2015-12, Vol.7 (4), p.352-362

2015

Volltextzugriff (PDF)

Plaque psoriasis in children and adolescents ndash; the role of etanercept

Psoriasis (Auckland, New Zealand), 2012-06, Vol.2012 (default), p.25-28

2012

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(61)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(31)
Physical Sciences
(19)
Chemistry
(16)
Dermatology
(16)
Humans
(16)
Psoriasis
(13)
Circular Dichroism
(12)
Female
(10)
Psoriasis - Drug Therapy
(10)
Middle Aged
(9)
Adult
(8)
Chemistry, Organic
(8)
Male
(8)
Aged
(7)
Antibodies, Monoclonal - Therapeutic Use
(7)
Biological And Medical Sciences
(7)
Etanercept
(7)
Dermatologic Agents - Therapeutic Use
(6)
Pharmacology & Pharmacy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical experience with infliximab biosimilar in psoriasis

Induced Preference Improves Offspring Fitness in a Phytopathogen Vector

Tuscan consensus on the diagnosis and treatment of hidradenitis suppurativa

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients

Lichen planus triggered by CT‐P13 and recurrence during secukinumab treatment

Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas

Clinical experience with the etanercept biosimilar SB4 in psoriatic patients

Risk of acute infections in psoriatic patients during biologic therapies is linked to gender

Clinical characteristics of psoriasis in inflammatory bowel disease patients

First case of secukinumab successful therapy in a very elderly psoriatic patient

Itch in psoriasis: epidemiology, clinical aspects and treatment options

Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature

Reduction in psoriasis related pruritus during biologic therapy

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study

Female mate preference in an invasive phytopathogen vector: how learning may influence mate choice and fecundity in Diaphorina citri

Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result

Development of MGUS in psoriatic patients: a possible undiagnosed event during anti-TNF-α-treatment

Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities

Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies

Tuberculosis reactivation risk in dermatology

Reduction in psoriasis related pruritus during biologic therapy: Pruritus control in moderate to severe psoriasis

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients: Anti-TNF-α in patients with HBV or HCV and psoriasis

Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result: Efficacy of acitretin in nail psoriasis

Cutaneous Non-Tuberculous Mycobacterial Infections: Clinical Clues and Treatment Options

Plaque psoriasis in children and adolescents ndash; the role of etanercept

Suchergebnisse filtern